SHAMIKA REED: Open Payments
NPI 1124511522 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$125 in 6 payments from 5 companies in 2025. Trend: 2023 $114 · 2024 $107 · 2025 $125
Food & beverage: $125
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 2 | $40 |
| Eisai Inc. | 1 | $33 |
| Merck Sharp & Dohme LLC | 1 | $20 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $18 |
| Astellas Pharma US Inc | 1 | $14 |
Products named: ERLEADA, Lenvima, KEYTRUDA, Nubeqa, Xtandi.
Industry payments across TX — which companies pay providers there.
